Company intelligence / Profile preview

Portage Pharmaceuticals

Road Town, Tortola, United Kingdom

Ownership: Private
Employees: ~25
Development stage: Other

Overview

The company is a clinical-stage immuno-oncology biotech with 10 products across five platforms, but as of 2025 has paused enrollment in lead adenosine receptor antagonist trials due to financial issues, and is considering closure or asset sales. Historical clinical readouts include initial Ph 1 for adenosine antagonists (PORT-6, PORT-7), no pivotal or registrational results available. Recent collaboration with Merck on combination with pembrolizumab was announced, but progress is uncertain due to funding constraints.

Therapeutic areas: OncologyOphthalmology
Modalities: Small moleculeAptamerNanoparticleLiposomeVirus-like particle
Industry: Biotech

Partnerships

Merck/MSD (Keytruda (pembrolizumab) combination trials for adenosine programs)Intensity Therapeutics (clinical supply collaboration, 2024)Juvenescence Ltd. (received milestone and royalty rights for divested legacy subsidiaries)

Beyond the preview

Go deeper on Portage Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Portage Pharmaceuticals.

Explore the full profile